LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Recommendation of “Buy” from Analysts
LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) has been given an average recommendation of “Buy” by the seven brokerages that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating on the […]
More Stories
Keyence Co. (OTCMKTS:KYCCF) Sees Significant Decrease in Short Interest
Keyence Co. (OTCMKTS:KYCCF – Get Free Report) was the target of a large drop in short interest during the month...
EnLink Midstream (NYSE:ENLC) Lowered to “Equal Weight” at Morgan Stanley
Morgan Stanley cut shares of EnLink Midstream (NYSE:ENLC – Free Report) from an overweight rating to an equal weight rating...
HC Wainwright Reaffirms “Buy” Rating for CG Oncology (NASDAQ:CGON)
HC Wainwright reiterated their buy rating on shares of CG Oncology (NASDAQ:CGON – Free Report) in a research note released...
DMC Global (NASDAQ:BOOM) PT Lowered to $17.00 at Stifel Nicolaus
DMC Global (NASDAQ:BOOM – Free Report) had its target price decreased by Stifel Nicolaus from $19.00 to $17.00 in a...
Cellectar Biosciences (NASDAQ:CLRB) Upgraded at StockNews.com
StockNews.com upgraded shares of Cellectar Biosciences (NASDAQ:CLRB – Free Report) to a sell rating in a research report sent to...
Conn’s (NASDAQ:CONN) Research Coverage Started at StockNews.com
StockNews.com started coverage on shares of Conn’s (NASDAQ:CONN – Free Report) in a research note released on Tuesday morning. The...